Veru (VERU) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

VERU Stock Forecast


Veru stock forecast is as follows: an average price target of $4.00 (represents a 518.24% upside from VERU’s last price of $0.65) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.

VERU Price Target


The average price target for Veru (VERU) is $4.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $3.00. This represents a potential 518.24% upside from VERU's last price of $0.65.

VERU Analyst Ratings


Buy

According to 7 Wall Street analysts, Veru's rating consensus is 'Buy'. The analyst rating breakdown for VERU stock is 0 'Strong Buy' (0.00%), 5 'Buy' (71.43%), 2 'Hold' (28.57%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Veru Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 03, 2024Yi ChenH.C. Wainwright$3.00$1.6779.64%363.68%
Apr 15, 2024Leland GershellOppenheimer$5.00$1.52228.95%672.80%
Dec 07, 2022H.C. Wainwright$18.00$5.66218.02%2682.07%
Apr 15, 2022Leland GershellOppenheimer$36.00$14.95140.80%5464.14%

The latest Veru stock forecast, released on May 03, 2024 by Yi Chen from H.C. Wainwright, set a price target of $3.00, which represents a 79.64% increase from the stock price at the time of the forecast ($1.67), and a 363.68% increase from VERU last price ($0.65).

Veru Price Target by Period


1M3M12M
# Anlaysts--2
Avg Price Target--$4.00
Last Closing Price$0.65$0.65$0.65
Upside/Downside-100.00%-100.00%518.24%

In the current month, the average price target of Veru stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Veru's last price of $0.65. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
May 14, 2024B. RileyBuyInitialise
May 06, 2024Raymond JamesBuyBuyHold
May 03, 2024H.C. WainwrightBuyBuyHold
Apr 15, 2024OppenheimerOutperformOutperformHold
Jun 07, 2023JefferiesBuyHoldUpgrade
Dec 05, 2022Cantor FitzgeraldOverweightOverweightHold
Jul 11, 2022OppenheimerOutperformOutperformHold
Jul 06, 2022JefferiesBuyBuyHold
May 13, 2022OppenheimerOutperformOutperformHold
May 13, 2022JefferiesBuyBuyHold
Apr 26, 2022Zacks Investment ResearchHoldDowngrade
Apr 14, 2022OppenheimerOutperformOutperformHold

Veru's last stock rating was published by B. Riley on May 14, 2024. The company Initialise its VERU rating from "null" to "Buy".

Veru Financial Forecast


Veru Revenue Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Revenue----------$2.14M$3.86M$3.34M$6.59M$2.51M$2.59M$9.60M$13.03M$14.14M$15.65M$17.66M$13.34M$14.62M$11.75M$10.32M$9.94M$10.58M$8.73M$9.73M$6.98M
Avg Forecast$1.70M$1.90M$2.10M$3.50M$3.50M$3.50M$3.50M$3.56M$3.50M$3.00M$3.90M$3.95M$6.21M$4.33M$5.07M$11.55M$16.67M$12.21M$13.84M$18.17M$14.10M$14.29M$10.92M$10.61M$10.74M$10.97M$8.77M$9.17M$8.06M$6.86M
High Forecast$1.90M$2.12M$2.34M$3.90M$3.90M$3.95M$3.86M$4.30M$3.90M$3.35M$5.90M$4.41M$6.93M$4.82M$5.65M$11.55M$16.67M$12.21M$13.84M$18.17M$14.10M$14.29M$10.92M$10.61M$10.74M$10.97M$8.77M$9.17M$8.06M$6.86M
Low Forecast$1.60M$1.79M$1.97M$3.29M$3.29M$3.27M$3.31M$3.00M$3.29M$2.82M$1.90M$3.71M$5.84M$4.07M$4.76M$11.55M$16.67M$12.21M$13.84M$18.17M$14.10M$14.29M$10.92M$10.61M$10.74M$10.97M$8.77M$9.17M$8.06M$6.86M
# Analysts221114454121111111111154544343
Surprise %----------0.55%0.98%0.54%1.52%0.49%0.22%0.58%1.07%1.02%0.86%1.25%0.93%1.34%1.11%0.96%0.91%1.21%0.95%1.21%1.02%

Veru's average Quarter revenue forecast for Mar 24 based on 1 analysts is $3.00M, with a low forecast of $2.82M, and a high forecast of $3.35M. VERU's average Quarter revenue forecast represents a 40.14% increase compared to the company's last Quarter revenue of $2.14M (Dec 23).

Veru EBITDA Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts221114454121111111111154544343
EBITDA----------$-8.80M$-11.84M$4.86M$-31.62M$-35.59M$-44.67M$-21.70M$-11.72M$-4.85M$-1.81M$-2.87M$-1.49M$767.35K$2.88M$-1.33M$-131.91K$-1.66M$-1.32M$-1.70M$-1.98M
Avg Forecast$-819.21K$-915.58K$-1.01M$-1.69M$-1.69M$-1.69M$-1.69M$-1.72M$-1.69M$-1.45M$-1.88M$-1.90M$-2.99M$-2.08M$-2.44M$-6.79M$-9.79M$-1.70M$-8.13M$-10.67M$-8.29M$-1.54M$-6.42M$-6.23M$-6.31M$530.91K$-5.15M$-5.39M$-4.73M$-2.63M
High Forecast$-770.25K$-860.87K$-951.49K$-1.59M$-1.59M$-1.58M$-1.59M$-1.45M$-1.59M$-1.36M$-917.83K$-1.79M$-2.82M$-1.96M$-2.30M$-6.79M$-9.79M$-1.36M$-8.13M$-10.67M$-8.29M$-1.24M$-6.42M$-6.23M$-6.31M$637.09K$-5.15M$-5.39M$-4.73M$-2.11M
Low Forecast$-913.86K$-1.02M$-1.13M$-1.88M$-1.88M$-1.90M$-1.86M$-2.07M$-1.88M$-1.61M$-2.84M$-2.12M$-3.34M$-2.32M$-2.72M$-6.79M$-9.79M$-2.04M$-8.13M$-10.67M$-8.29M$-1.85M$-6.42M$-6.23M$-6.31M$424.73K$-5.15M$-5.39M$-4.73M$-3.16M
Surprise %----------4.68%6.22%-1.62%15.17%14.58%6.58%2.22%6.89%0.60%0.17%0.35%0.97%-0.12%-0.46%0.21%-0.25%0.32%0.25%0.36%0.75%

1 analysts predict VERU's average Quarter EBITDA for Sep 23 to be $-1.90M, with a high of $-1.79M and a low of $-2.12M. This is -139.17% lower than Veru's previous annual EBITDA (Jun 23) of $4.86M.

Veru Net Income Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts221114454121111111111154544343
Net Income----------$-8.28M$-23.77M$6.31M$-38.79M$-36.84M$-41.02M$-22.20M$-14.18M$-6.38M$-4.29M$-2.69M$-2.85M$17.23M$-11.83M$-3.03M$-810.51K$-3.31M$-3.06M$-2.77M$-4.03M
Avg Forecast$-14.64M$-13.17M$-11.71M$-10.25M$-10.25M$-10.25M$-10.25M$-12.42M$-8.49M$-7.81M$-17.57M$-34.40M$-29.76M$-48.67M$-55.14M$-44.28M$-23.42M$-3.13M$-13.76M$-13.47M$-8.78M$-2.85M$-6.95M$-5.37M$-4.76M$-1.28M$-3.42M$-7.32M$-6.34M$-4.03M
High Forecast$-13.50M$-12.15M$-10.80M$-9.45M$-9.45M$-9.45M$-9.45M$-12.38M$-7.83M$-7.20M$-10.81M$-31.73M$-27.45M$-44.89M$-50.85M$-44.28M$-23.42M$-2.50M$-13.76M$-13.47M$-8.78M$-2.28M$-6.95M$-5.37M$-4.76M$-1.02M$-3.42M$-7.32M$-6.34M$-3.23M
Low Forecast$-16.84M$-15.15M$-13.47M$-11.79M$-11.79M$-11.79M$-11.79M$-12.46M$-9.77M$-8.98M$-20.27M$-39.57M$-34.23M$-55.98M$-63.42M$-44.28M$-23.42M$-3.76M$-13.76M$-13.47M$-8.78M$-3.42M$-6.95M$-5.37M$-4.76M$-1.53M$-3.42M$-7.32M$-6.34M$-4.84M
Surprise %----------0.47%0.69%-0.21%0.80%0.67%0.93%0.95%4.53%0.46%0.32%0.31%1.00%-2.48%2.20%0.64%0.63%0.97%0.42%0.44%1.00%

Veru's average Quarter net income forecast for Sep 23 is $-34.40M, with a range of $-39.57M to $-31.73M. VERU's average Quarter net income forecast represents a -644.80% decrease compared to the company's last Quarter net income of $6.31M (Jun 23).

Veru SG&A Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts221114454121111111111154544343
SG&A----------$8.30M$6.77M$10.90M$12.83M$17.55M$18.29M$10.76M$7.40M$6.72M$5.92M$5.56M$4.81M$4.38M$3.46M$3.48M$3.81M$3.75M$3.69M$3.55M$3.82M
Avg Forecast$1.76M$1.97M$2.17M$3.62M$3.62M$3.62M$3.62M$3.68M$3.62M$3.10M$4.04M$4.09M$6.43M$4.48M$5.24M$11.95M$17.25M$5.29M$14.33M$18.80M$14.59M$4.81M$11.30M$10.98M$11.11M$5.99M$9.07M$9.49M$8.34M$3.82M
High Forecast$1.96M$2.19M$2.42M$4.04M$4.04M$4.09M$3.99M$4.45M$4.04M$3.46M$6.10M$4.56M$7.18M$4.99M$5.85M$11.95M$17.25M$6.35M$14.33M$18.80M$14.59M$5.77M$11.30M$10.98M$11.11M$7.19M$9.07M$9.49M$8.34M$4.59M
Low Forecast$1.65M$1.85M$2.04M$3.41M$3.41M$3.39M$3.42M$3.10M$3.41M$2.92M$1.97M$3.84M$6.05M$4.21M$4.93M$11.95M$17.25M$4.23M$14.33M$18.80M$14.59M$3.85M$11.30M$10.98M$11.11M$4.80M$9.07M$9.49M$8.34M$3.06M
Surprise %----------2.06%1.66%1.70%2.87%3.35%1.53%0.62%1.40%0.47%0.32%0.38%1.00%0.39%0.32%0.31%0.63%0.41%0.39%0.43%1.00%

Veru's average Quarter SG&A projection for Mar 24 is $3.10M, based on 1 Wall Street analysts, with a range of $2.92M to $3.46M. The forecast indicates a -62.60% fall compared to VERU last annual SG&A of $8.30M (Dec 23).

Veru EPS Forecast

Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts221114454121111111111154544343
EPS----------$-0.08$-0.28$0.07$-0.48$-0.46$-0.51$-0.28$-0.18$-0.08$-0.05$-0.03$-0.04$0.25$-0.17$-0.05$-0.01$-0.05$-0.05$-0.04$-0.06
Avg Forecast$-0.10$-0.09$-0.08$-0.07$-0.07$-0.07$-0.07$-0.08$-0.06$-0.05$-0.12$-0.23$-0.20$-0.33$-0.38$-0.30$-0.16$-0.14$-0.09$-0.09$-0.06$-0.04$-0.05$-0.04$-0.03$-0.04$-0.02$-0.05$-0.04$-0.06
High Forecast$-0.09$-0.08$-0.07$-0.06$-0.06$-0.06$-0.06$-0.08$-0.05$-0.05$-0.07$-0.22$-0.19$-0.31$-0.35$-0.30$-0.16$-0.14$-0.09$-0.09$-0.06$-0.04$-0.05$-0.04$-0.03$-0.04$-0.02$-0.05$-0.04$-0.06
Low Forecast$-0.12$-0.10$-0.09$-0.08$-0.08$-0.08$-0.08$-0.09$-0.07$-0.06$-0.14$-0.27$-0.23$-0.38$-0.43$-0.30$-0.16$-0.14$-0.09$-0.09$-0.06$-0.04$-0.05$-0.04$-0.03$-0.04$-0.02$-0.05$-0.04$-0.06
Surprise %----------0.69%1.19%-0.35%1.44%1.22%1.69%1.75%1.27%0.85%0.58%0.56%1.00%-5.26%4.64%1.39%0.29%2.18%0.94%1.02%1.12%

According to 1 Wall Street analysts, Veru's projected average Quarter EPS for Sep 23 is $-0.23, with a low estimate of $-0.27 and a high estimate of $-0.22. This represents a -428.67% decrease compared to VERU previous annual EPS of $0.07 (Jun 23).

Veru Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
LXRXLexicon Pharmaceuticals$0.73$6.00721.92%Buy
VERUVeru$0.71$4.00463.38%Buy
ANVSAnnovis Bio$5.11$25.50399.02%Buy
NVAXNovavax$9.00$20.33125.89%Buy
IOVAIovance Biotherapeutics$7.81$12.4058.77%Buy
SRPTSarepta Therapeutics$125.76$187.2048.85%Buy
AXSMAxsome Therapeutics$93.51$133.0042.23%Buy
MCRBSeres Therapeutics$0.88$1.2542.05%Buy
AVXLAnavex Life Sciences$9.21$11.0019.44%Buy
TSVT2seventy bio$3.21$2.00-37.69%Buy

VERU Forecast FAQ


Is Veru a good buy?

Yes, according to 7 Wall Street analysts, Veru (VERU) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 71.43% of VERU's total ratings.

What is VERU's price target?

Veru (VERU) average price target is $4 with a range of $3 to $5, implying a 518.24% from its last price of $0.647. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Veru stock go up soon?

According to Wall Street analysts' prediction for VERU stock, the company can go up by 518.24% (from the last price of $0.647 to the average price target of $4), up by 672.80% based on the highest stock price target, and up by 363.68% based on the lowest stock price target.

Can Veru stock reach $1?

VERU's average twelve months analyst stock price target of $4 supports the claim that Veru can reach $1 in the near future.

What are Veru's analysts' financial forecasts?

Veru's analysts financial forecasts for the fiscal year (Sep 2024) are as follows: average revenue is $13.96M (high $17.45M, low $11.02M), average EBITDA is $-6.727M (high $-5.309M, low $-8.407M), average net income is $-46.283M (high $-38.221M, low $-51.473M), average SG&A $14.45M (high $18.06M, low $11.4M), and average EPS is $-0.316 (high $-0.261, low $-0.352). VERU's analysts financial forecasts for the fiscal year (Sep 2025) are as follows: average revenue is $14M (high $15.62M, low $13.16M), average EBITDA is $-6.746M (high $-6.343M, low $-7.526M), average net income is $-40.987M (high $-37.803M, low $-47.144M), average SG&A $14.49M (high $16.16M, low $13.62M), and average EPS is $-0.28 (high $-0.258, low $-0.322).

Did the VERU's actual financial results beat the analysts' financial forecasts?

Based on Veru's last annual report (Sep 2022), the company's revenue was $39.35M, which missed the average analysts forecast of $54.27M by -27.48%. Apple's EBITDA was $-83.224M, beating the average prediction of $-26.412M by 215.09%. The company's net income was $-83.776M, missing the average estimation of $-84.593M by -0.97%. Apple's SG&A was $43.17M, missing the average forecast of $48.82M by -11.57%. Lastly, the company's EPS was $-1.05, beating the average prediction of $-0.699 by 50.32%. In terms of the last quarterly report (Dec 2023), Veru's revenue was $2.14M, missing the average analysts' forecast of $3.9M by -45.11%. The company's EBITDA was $-8.801M, beating the average prediction of $-1.879M by 368.30%. Veru's net income was $-8.276M, missing the average estimation of $-17.566M by -52.89%. The company's SG&A was $8.3M, beating the average forecast of $4.04M by 105.67%. Lastly, the company's EPS was $-0.0823, missing the average prediction of $-0.12 by -31.42%